Table 1 Risk of second cancer by age
From: Impact of race and tumor subtype on second malignancy risk in women with breast cancer
Under 50 | 50 and older | |||||||
|---|---|---|---|---|---|---|---|---|
Observed | O/E | Excess risk | Mean age at event | Observed | O/E | Excess risk | Mean age at event | |
All sites | 16,492 | 1.64# | 43.06 | 54.64 | 58,378 | 1.10# | 15.01 | 74.42 |
All solid tumors | 15,479 | 1.68# | 41.91 | 54.48 | 52,829 | 1.13# | 17.32 | 74.2 |
Oral cavity and pharynx | 204 | 1.25# | 0.27 | 55.68 | 915 | 1.04 | 0.11 | 74.1 |
Digestive system | 1481 | 1.07# | 0.61 | 59.52 | 11,942 | 0.98 | −0.6 | 77.01 |
Colon, rectum and anus | 808 | 0.94 | −0.36 | 59.13 | 7569 | 0.98 | −0.34 | 77.15 |
Pancreas | 237 | 1.22# | 0.28 | 60.83 | 1734 | 0.95# | −0.28 | 77.03 |
Peritoneum, omentum and mesentery | 45 | 2.04# | 0.15 | 59.65 | 110 | 0.94 | −0.02 | 74.85 |
Respiratory system | 1555 | 1.28# | 2.29 | 59.76 | 7790 | 0.97# | −0.78 | 74.11 |
Bones and joints | 25 | 2.01# | 0.08 | 53.86 | 50 | 1.1 | 0.01 | 72.67 |
Soft tissue including heart | 110 | 2.14# | 0.39 | 54.64 | 334 | 1.39# | 0.27 | 74.43 |
Skin excluding basal and squamous | 525 | 1.21# | 0.61 | 54.16 | 1604 | 1.12# | 0.48 | 74.49 |
Breast | 8696 | 2.37# | 33.49 | 52.44 | 19,175 | 1.36# | 14.45 | 72.76 |
Female genital system | 1877 | 1.35# | 3.21 | 54.84 | 6909 | 1.19# | 3.17 | 73.36 |
Corpus and uterus, NOS | 903 | 1.21# | 1.05 | 56.38 | 4262 | 1.36# | 3.26 | 73.25 |
Ovary | 720 | 1.99# | 2.39 | 53.05 | 1785 | 1.07# | 0.32 | 72.97 |
Urinary system | 469 | 1.14# | 0.4 | 59.24 | 2997 | 1.04 | 0.29 | 75.86 |
Brain and other nervous system | 120 | 1.06 | 0.04 | 54.58 | 395 | 0.75# | −0.37 | 72.7 |
Endocrine system | 429 | 1.25# | 0.57 | 52.14 | 806 | 1.28# | 0.51 | 69.21 |
Lymphoma | 361 | 0.94 | −0.16 | 58.64 | 2145 | 0.91# | −0.63 | 76.54 |
Leukemia | 352 | 1.90# | 1.11 | 53.62 | 1551 | 1.08# | 0.31 | 75.51 |